Actome
Pre-clinicalThe PICO technology is an innovative immunoassay for the absolute quantification of extracellular vesicles, proteins, protein interactions, and protein modifications using digital PCR.
Founded
2018
Focus
ProteomicsAI / Machine Learning
About
The PICO technology is an innovative immunoassay for the absolute quantification of extracellular vesicles, proteins, protein interactions, and protein modifications using digital PCR.
Funding History
2Total raised: $24.5M
Series A$20MBioMedPartnersMar 15, 2023
Seed$4.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationBerlin, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile